TAIWAN · TWSE / TPEx
WELGENE
威健生技 · 6661 · TPEx (OTC) · Biotech and medical
Share price, 2026-10-19NT$17.101 month +3.0% · 1 year -26.6%
Directors and supervisors hold8,588,32436.9% of shares issued
Of which pledged0.0%0
Major shareholders (10%+) hold7,481,33332.1% of shares issued
Revenue, 2026-09+19.6%year on year
Share price, last 12 months
Daily closes adjusted for cash and stock dividends, against the TAIEX index rebased to the same start. Prices from Yahoo Finance.
Directors, officers and major shareholders
Holdings reported for 2026-09. At election = shares held when the director was elected. Related parties = holdings of the person's spouse, minor children and nominees. One person with two roles is listed once.
| Person | Role | At election | Now | Of the company | Pledged | Related parties |
|---|---|---|---|---|---|---|
| 陳貴弘 | Chairman | 488,527 | 488,527 | 2.10% | — | — |
| 漢碁股份有限公司 | Director · Major shareholder (10%+) | 7,063,333 | 7,481,333 | 32.10% | — | — |
| 郭奕靚 | Director (corporate representative) | — | 0 | — | — | 488,527 |
| 林怡杏 | Director · President | 326,847 | 326,847 | 1.40% | — | 12,684 |
| 林家綺 | Director | 291,617 | 291,617 | 1.25% | — | — |
| 吳兆原 | Independent director | — | 0 | — | — | — |
| 楊運澄 | Independent director | — | 0 | — | — | — |
| 李彥伶 | Independent director | — | 0 | — | — | — |
| 陳盈任 | Vice president · Chief financial officer · Chief accountant | — | 79,000 | 0.34% | — | — |
| 顏廷銓 | Vice president | — | 0 | — | — | — |
| 劉原良 | Vice president | — | 0 | — | — | — |